Lifeline sets date for Solos Endoscopy stock dividend

By Elaine Rigoli

Tampa, Fla., July 24 - Lifeline Biotechnologies, Inc. said it established the record date of Aug. 18 for the issuance of a special stock dividend to its shareholders.

Lifeline shareholders will receive one new share of Solos Endoscopy, Inc. for approximately every 100 shares of Lifeline they own as of the record date.

Solos obtained medical assets from Lifeline for $4 million in restricted shares of Solos. The medical assets will include the MastaScope, First Warning System, OvaScope and the inventory and intellectual properties relating to those products.

Lifeline will also receive compensation, in the form of a royalty, once sales of those products exceed $4 million.

Solos is a health care technology company based in Boston.

Lifeline is a biotechnology company based in Reno, Nev.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.